A study paradigm allowing comparison of multiple high-resolution rCBV-maps for the examination of drug effects

NMR in Biomedicine

Volumn 18, Issue 4, 2005, Pages 260-268

  Rausch, Martin ^a   Gentsch, C ^a   Enz, A ^a   Baumann, D ^a   Rudin, M ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

AMI 25; Co registration; Rat; rCBV; Rivastigmine

Indexed keywords

BLOOD; BRAIN; NEURAL NETWORKS; NUCLEAR MAGNETIC RESONANCE; ORGANIC COMPOUNDS;

BLOOD FLOWS; BLOOD VOLUME; CO-REGISTRATION PROCEDURE; NEURO-VASCULAR COUPLING;

DRUG DOSAGE;

CONTRAST MEDIUM; GALLAMINE; RIVASTIGMINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD ANALYSIS; BLOOD VOLUME; BRAIN BLOOD FLOW; BRAIN CORTEX; CAUDATE NUCLEUS; CONTRAST RADIOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ELECTRON SPIN RESONANCE; HIPPOCAMPUS; IMAGE ANALYSIS; MALE; MATHEMATICAL COMPUTING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; PUTAMEN; RAT; RAT STRAIN; THREE DIMENSIONAL IMAGING;

ADMINISTRATION, ORAL; ANIMALS; BRAIN; CEREBROVASCULAR CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; PHENYLCARBAMATES; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; SUBTRACTION TECHNIQUE;

ANIMALIA;

EID: 21644482243     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.956     Document Type: Article

References (19)

1. Buxton RB, Frank LR. A model for the coupling between cerebral blood flow and oxygen metabolism during neural stimulation. J. Cereb. Blood Flow Metab. 1997; 17: 64-72.
2. Mandeville JB, Jenkins BG, Kosofsky BE, Moskowitz MA, Rosen BR, Marota JJ. Regional sensitivity and coupling of BOLD and CBV changes during stimulation of rat brain. Magn. Reson. Med. 2001; 45: 443-447.
3. Kennan RP, Scanley BE, Innis RB, Gore JC. Physiological basis for BOLD MR signal changes due to neuronal stimulation: separation of blood volume and magnetic susceptibility effects. Magn. Reson. Med. 1998; 40: 840-846.
4. Scheffler K, Seifritz E, Haselhorst R, Bilecen D. Titration of the BOLD effect: separation and quantitation of blood volume and oxygenation changes in the human cerebral cortex during neuronal activation and ferumoxide infusion. Magn. Reson. Med. 1999; 42: 829-836.
5. Alsop DC, Detre JA, Grossman M. Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann. Neurol. 2000; 47: 93-100.
6. Reese T, Bjelke B, Porszasz R, Baumann D, Bochelen D, Sauter A, Rudin M. Regional brain activation by bicuculline visualized by functional magnetic resonance imaging. Time-resolved assessment of bicuculline-induced changes in local cerebral blood volume using an intravascular contrast agent. NMR Biomed. 2000; 13: 43-49.
7. Mueggler T, Sturchler-Pierrat C, Baumann D, Rausch M, Staufenbiel M, Rudin M. Compromised hemodynamic response in amyloid precursor protein transgenic mice. J. Neurosci. 2002; 22: 7218-7224.
8. Chen YC, Galpern WR, Brownell AL, Matthews RT, Bogdanov M, Isacson O, Keltner JR, Beal MF, Rosen BR, Jenkins BG. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magn. Reson. Med. 1997; 38: 389-398.
9. Mandeville JB, Marota JJ, Kosofsky BE, Keltner JR, Weissleder R, Rosen BR, Weisskoff RM. Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn. Reson. Med. 1998; 39: 615-624.
10. Preece M, Mukherjee B, Huang CL, Hall LD, Leslie RA, James MF. Detection of pharmacologically mediated changes in cerebral activity by functional magnetic resonance imaging: the effects of sulpiride in the brain of the anaesthetised rat. Brain Res. 2001; 916: 107-114.
11. Enz A, Boddeke H, Gray J, Spiegel R. Pharmacologic and clinicopharmacologic properties of SDZ ENA 713, a centrally selective acetylcholinesterase inhibitor. Ann. NY Acad. Sci. 1991; 640: 272-275.
12. Dykes RW. Mechanisms controlling neuronal plasticity in somatosensory cortex. Can. J. Physiol. Pharm. 1997; 75: 535-545.
13. Dani JA. Overview of nicotinic receptors and their roles in the central nervous system. Biol. Psychiat. 2001; 49: 166-174.
14. Farkas E, Luiten PG. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 2001; 64: 575-611.
15. Woods RP, Mazziotta JC, Cherry SR. MRI-PET registration with automated algorithm. J. Comput. Assist. Tomogr. 1993; 4: 536-546.
16. Friston KJ, Holmes AP, Worsley KJ, Poline J-B, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: a general linear approach. Hum. Brain Mapp. 1995; 2: 189-210.
17. Mueggler T, Baumann D, Rausch M, Rudin M. Bicuculline-induced brain activation in mice detected by functional magnetic resonance imaging. Magn. Reson. Med. 2001; 46: 292-298.
18. Aguirre GK, Zarahn E, D'Esposito M. The inferential impact of global signal covariates in functional neuroimaging analyses. Neuroimage 1998; 8: 302-306.
19. Friston KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak RS. The relationship between global and local changes in PET scans. J. Cereb. Blood Flow Metab. 1990; 10: 458-466.